Skip to content

Effects of Apple polyphenols on carbohydrate and lipid metabolism in Human study : A randomized, double-blinded, placebo-controlled trial

Effects of Apple polyphenols on carbohydrate and lipid metabolism in Human study : A randomized, double-blinded, placebo-controlled trial - Apple polyphenols and anti-diabetes study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000011751
Enrollment
120
Registered
2013-09-20
Start date
2013-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prediabetes

Interventions

12 weeks, 4 tablets / day Placebo group 12 weeks, 4 tablets / day AP600mg group 12 weeks, 4 tablets / day AP900mg group

Sponsors

National Institute of Fruit Tree Science, National Agriculture & Food Research
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: fasting blood glucose 100<=130>=

Exclusion criteria

Exclusion criteria: A person who has regular supplements such as grape seed and tea polyphenols. A person who has participated in other clinical trials in this study at the start. So far, by ingestion of polyphenol and Apple, who has ever complained of a disorder of the body. 1. A person with a history heart failure, myocardial infarction. 2. Treatment of atrial fibrillation, hypertension, arrhythmia, liver failure, renal failure, cerebrovascular disease, arthritis, diabetes, hyperlipidemia, such as anemia. 3. A person have (food, medicine) and allergy history. 4. Pregnant women, nursing mothers 5. Others, who the investigator has determined to be inappropriate as a target for this study.

Design outcomes

Primary

MeasureTime frame
Glucose, insuline

Secondary

MeasureTime frame
C-peptide, TNF-a, IL-6, IL-1b, leptin, adiponectin, PAI-1, MCP-1, GLP-1

Countries

Japan

Contacts

Public ContactMitsuhiro Yamada

Kakegawa city Health and Prevention Division

m-yamada@city.kakegawa.shizuoka.jp0537-23-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026